COVID-19: Immunology and treatment options

S Felsenstein, JA Herbert, PS McNamara… - Clinical …, 2020‏ - Elsevier
The novel coronavirus SARS-CoV2 causes COVID-19, a pandemic threatening millions. As
protective immunity does not exist in humans and the virus is capable of esca** innate …

[HTML][HTML] ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19

M Dong, J Zhang, X Ma, J Tan, L Chen, S Liu… - Biomedicine & …, 2020‏ - Elsevier
At the end of 2019, the coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Currently, it is …

[HTML][HTML] COVID-19 associated with pulmonary aspergillosis: A literature review

CC Lai, WL Yu - Journal of Microbiology, Immunology and Infection, 2021‏ - Elsevier
Bacterial or virus co-infections with severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) have been reported in many studies, however, the knowledge on Aspergillus co …

Cardiovascular implications of the COVID-19 pandemic: a global perspective

M Boukhris, A Hillani, F Moroni, MS Annabi… - Canadian Journal of …, 2020‏ - Elsevier
Abstract The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), represents the pandemic of the century, with …

SARS-CoV-2 infection and cardiovascular disease: COVID-19 heart

BP Dhakal, NK Sweitzer, JH Indik, D Acharya… - Heart, lung and …, 2020‏ - Elsevier
Coronavirus disease (COVID-19) is a serious illness caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). The symptoms of the disease range from …

HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic: Developed in partnership with …

N Varma, NF Marrouche, L Aguinaga, CM Albert… - EP …, 2021‏ - academic.oup.com
For copies of this document, please contact the Elsevier Inc. Reprint Department (reprints@
elsevier. com). Permissions: Multiple copies, modification, alteration, enhancement, and/or …

An updated systematic review of the therapeutic role of hydroxychloroquine in coronavirus disease-19 (COVID-19)

S Das, S Bhowmick, S Tiwari, S Sen - Clinical drug investigation, 2020‏ - Springer
Abstract Background and Objective The world is currently experiencing the Coronavirus
Disease-19 (COVID-19) pandemic. There is no approved drug for the definitive treatment of …

[HTML][HTML] Advances in the relationship between coronavirus infection and cardiovascular diseases

M Zhao, M Wang, J Zhang, J Ye, Y Xu, Z Wang… - Biomedicine & …, 2020‏ - Elsevier
The outbreak of coronavirus disease 2019 (COVID-19) has once again aroused people's
concern about coronavirus. Seven human coronaviruses (HCoVs) have been discovered so …

[HTML][HTML] COVID-19 and arrhythmia: An overview

JA Varney, VS Dong, T Tsao, MS Sabir, AT Rivera… - Journal of …, 2022‏ - Elsevier
Arrhythmias in COVID-19 patients are associated with hypoxia, myocardial ischemia,
cytokines, inflammation, electrolyte abnormalities, pro-arrhythmic or QT-prolonging …

Value of electrocardiography in coronavirus disease 2019 (COVID-19)

S Haseeb, EE Gul, G Çinier, G Bazoukis… - Journal of …, 2020‏ - Elsevier
In December 2019, reports of an unknown pneumonia not responsive to traditional
treatments arose in Wuhan, China. The pathogen was subsequently identified as severe …